Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Volume 319, Issue 2, Pages L325-L336
Publisher
American Physiological Society
Online
2020-07-09
DOI
10.1152/ajplung.00189.2020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer
- (2020) Sufang Tian et al. Journal of Thoracic Oncology
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia
- (2020) Feng Pan et al. RADIOLOGY
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
- (2020) Hao Xu et al. International Journal of Oral Science
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Increased sFLT1/PlGF ratio in COVID‐19: a novel link to Angiotensin II‐mediated endothelial dysfunction
- (2020) Valentina Giardini et al. AMERICAN JOURNAL OF HEMATOLOGY
- Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients
- (2020) Sana Salehi et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
- (2020) Katherine Mackey et al. ANNALS OF INTERNAL MEDICINE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
- (2020) Naveed Sattar et al. CIRCULATION
- COVID-19 and Cardiovascular Disease
- (2020) Kevin J. Clerkin et al. CIRCULATION
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study
- (2020) Sun-Young Jung et al. CLINICAL INFECTIOUS DISEASES
- Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
- (2020) Pingzheng Mo et al. CLINICAL INFECTIOUS DISEASES
- Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission
- (2020) Jennifer Lighter et al. CLINICAL INFECTIOUS DISEASES
- SARS ‐CoV‐2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells
- (2020) Soeren Lukassen et al. EMBO JOURNAL
- Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study
- (2020) Guang Yang et al. HYPERTENSION
- Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis
- (2020) Xiaoming Guo et al. HYPERTENSION
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
- (2020) Matt Arentz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
- (2020) Graziano Onder et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ramipril in High Risk Patients with COVID-19
- (2020) Ignacio J. Amat-Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
- (2020) Francisco J de Abajo et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation
- (2020) Arthur Simonnet et al. Obesity
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
- (2020) Barry Rockx et al. SCIENCE
- Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers
- (2020) Riccardo Sarzani et al. European Journal of Preventive Cardiology
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Neil Mehta et al. JAMA Cardiology
- Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
- (2020) Riccardo M. Inciardi et al. JAMA Cardiology
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Tao Guo et al. JAMA Cardiology
- Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
- (2020) Juyi Li et al. JAMA Cardiology
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
- (2020) Shaobo Shi et al. JAMA Cardiology
- Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality
- (2020) Emil L. Fosbøl et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Alamandine attenuates arterial remodelling induced by transverse aortic constriction in mice
- (2019) Fernando Pedro de Souza-Neto et al. CLINICAL SCIENCE
- The Renin-Angiotensin System: Going Beyond the Classical Paradigms
- (2019) Robson A. Souza Santos et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded “Double-Trouble” Lipid Profile in Overweight/Obese
- (2019) Francesco Spannella et al. ADVANCES IN THERAPY
- Sex differences in the metabolic effects of the renin-angiotensin system
- (2019) Melissa C. White et al. Biology of Sex Differences
- Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-β1 in alveolar epithelial cells
- (2019) Min Shao et al. BIOMEDICINE & PHARMACOTHERAPY
- Counter-regulatory renin–angiotensin system in cardiovascular disease
- (2019) Maria Paz Ocaranza et al. Nature Reviews Cardiology
- Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
- (2019) Lauren B. Arendse et al. PHARMACOLOGICAL REVIEWS
- Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan
- (2019) Richard T. Clements et al. Circulation-Heart Failure
- Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis
- (2019) Jay Ramchand et al. JACC-Cardiovascular Imaging
- Oral formulation angiotensin-(1-7) therapy attenuates pulmonary and systemic damage in mice with emphysema induced by elastase
- (2019) Aline Cândida Bastos et al. IMMUNOBIOLOGY
- ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway
- (2019) Rensong Ye et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes
- (2018) Itamar Couto Guedes de Jesus et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Renin-Angiotensin System Blockers and Statins Are Associated With Lower In-Hospital Mortality in Very Elderly Hypertensives
- (2018) Francesco Spannella et al. Journal of the American Medical Directors Association
- Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation
- (2018) Pan Liu et al. KIDNEY INTERNATIONAL
- Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor
- (2018) Seung Ah Cha et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Angiotensin-(1–7) Promotes Resolution of Eosinophilic Inflammation in an Experimental Model of Asthma
- (2018) Giselle S. Magalhaes et al. Frontiers in Immunology
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. JOURNAL OF HYPERTENSION
- Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
- (2018) Brian P Halliday et al. LANCET
- Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors/AT1 blockers
- (2017) Francesco Spannella et al. JOURNAL OF HYPERTENSION
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1–7)-Mas axes in pressure overload-induced cardiac remodeling in male mice
- (2016) Xingxu Wang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- NT-proBNP and Its Correlation with In-Hospital Mortality in the Very Elderly without an Admission Diagnosis of Heart Failure
- (2016) Riccardo Sarzani et al. PLoS One
- Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
- (2016) Hongjing Gu et al. Scientific Reports
- Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation
- (2015) G S Magalhães et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats
- (2015) Marilda L.A. De Maria et al. PROTEIN AND PEPTIDE LETTERS
- Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
- (2014) M. Furuhashi et al. AMERICAN JOURNAL OF HYPERTENSION
- Autocrine and Paracrine Function of Angiotensin 1-7 in Tissue Repair During Hypertension
- (2014) W. Meng et al. AMERICAN JOURNAL OF HYPERTENSION
- Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor–Dependent Mechanism
- (2014) Matthew R. Deshotels et al. HYPERTENSION
- Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension
- (2014) Vinayak Shenoy et al. HYPERTENSION
- Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis
- (2014) Maria Paz Ocaranza et al. JOURNAL OF HYPERTENSION
- Urinary angiotensin-converting enzyme 2 increases in diabetic nephropathy by angiotensin II type 1 receptor blocker olmesartan
- (2014) Masanori Abe et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
- (2014) Zhen Zou et al. Nature Communications
- Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
- (2014) Penghui Yang et al. Scientific Reports
- Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models
- (2013) Vinayak Shenoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Axis Protects against Lung Fibrosis by Inhibiting the MAPK/NF-κB Pathway
- (2013) Ying Meng et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Plasma Aldosterone Is Increased in Class 2 and 3 Obese Essential Hypertensive Patients Despite Drug Treatment
- (2012) R. Sarzani et al. AMERICAN JOURNAL OF HYPERTENSION
- Angiotensin Converting Enzyme 2 Contributes to Sex Differences in the Development of Obesity Hypertension in C57BL/6 Mice
- (2012) Manisha Gupte et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cardiac Complications in Patients With Community-Acquired Pneumonia
- (2012) Vicente F. Corrales-Medina et al. CIRCULATION
- Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
- (2012) D. Caldeira et al. BMJ-British Medical Journal
- Angiotensin signalling in pulmonary fibrosis
- (2011) Bruce D. Uhal et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The Angiotensin-Converting Enzyme 2/Angiogenesis-(1–7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension
- (2010) Vinayak Shenoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
- (2010) JiuChang Zhong et al. CIRCULATION
- Gender and the renin-angiotensin-aldosterone system
- (2010) Kimiaki Komukai et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia
- (2009) Hong Peng Jia et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
- (2009) G. Y. Oudit et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Renin–angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans
- (2009) Riccardo Sarzani et al. JOURNAL OF HYPERTENSION
- Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
- (2009) I. Glowacka et al. JOURNAL OF VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started